|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 267, Issue 6 1472-R1478, Copyright © 1994 by American Physiological Society
ARTICLES |
A. M. Alberola, F. J. Salazar, T. Nakamura and J. P. Granger
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505.
Recent in vitro studies have provided evidence that the vasoconstrictor actions of angiotensin II on afferent arterioles are enhanced by nitric oxide synthesis inhibition. Although these studies suggest that nitric oxide may play a role in protecting the afferent arterioles from angiotensin II-induced vasoconstriction, the importance of this interaction in the regulation of glomerular filtration rate and renal blood flow in the intact, conscious animal is not known. The objective of the present study was to determine the role of nitric oxide in modulating the renal hemodynamic and excretory effects of angiotensin II. Angiotensin II was infused at rates of 0.5, 1.0, and 2.0 micrograms.kg-1.min-1 intrarenally in conscious, chronically instrumented dogs in both the presence and absence of nitric oxide synthesis inhibition by continuous intrarenal infusion of NG-nitro-L-arginine methyl ester (3 micrograms.kg-1.min-1). At a dose of 0.5 micrograms.kg-1.min-1, angiotensin II decreased renal plasma flow by 19%, while having no effect on glomerular filtration rate in control dogs. In contrast, angiotensin II decreased renal plasma flow by 54%, glomerular filtration rate by 40%, and increased renal vascular resistance by 125% in the presence of intrarenal nitric oxide synthesis blockade. At doses of 1.0 and 2.0 micrograms.kg-1.min-1, angiotensin II reduced renal plasma flow by 36 and 45%, glomerular filtration rate by 17 and 23%, and increased renal vascular resistance by 80 and 120%, respectively, in control dogs.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
D. S. A. Majid, A. Nishiyama, K. E. Jackson, and A. Castillo Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthase inhibition in anesthetized dogs Am J Physiol Renal Physiol, February 1, 2005; 288(2): F412 - F419. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lopez, M. T. Llinas, F. Roig, and F. J. Salazar Role of nitric oxide and cyclooxygenase-2 in regulating the renal hemodynamic response to norepinephrine Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R488 - R493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Lansang and N. K. Hollenberg Renal Perfusion and the Renal Hemodynamic Response to Blocking the Renin System in Diabetes: Are the Forces Leading to Vasodilation and Vasoconstriction Linked? Diabetes, July 1, 2002; 51(7): 2025 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Alexander, W. A. Bennett, R. A. Khalil, and J. P. Granger Preeclampsia: Linking Placental Ischemia with Cardiovascular-Renal Dysfunction Physiology, December 1, 2001; 16(6): 282 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Raij Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction Hypertension, February 1, 2001; 37(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Berthold, A. Just, H. R. Kirchheim, and H. Ehmke Interaction Between Nitric Oxide and Endogenous Vasoconstrictors in Control of Renal Blood Flow Hypertension, December 1, 1999; 34(6): 1254 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu, H. Murakami, and I. H. Zucker Angiotensin II–Nitric Oxide Interaction on Sympathetic Outflow in Conscious Rabbits Circ. Res., March 9, 1998; 82(4): 496 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fitzgerald, K. M. Stevenson, R. G. Evans, and W. P. Anderson Systemic hemodynamic responses to chronic angiotensin II infusion into the renal artery of dogs Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1980 - R1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Deng, W. J. Welch, and C. S. Wilcox Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal Hemodynamics Hypertension, May 1, 1996; 27(5): 1173 - 1179. [Abstract] [Full Text] |
||||
![]() |
C. G. Schnackenberg, F. C. Wilkins, and J. P. Granger Role of Nitric Oxide in Modulating the Vasoconstrictor Actions of Angiotensin II in Preglomerular and Postglomerular Vessels in Dogs Hypertension, December 1, 1995; 26(6): 1024 - 1029. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |